These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8705261)

  • 21. Relationship between hepatocellular carcinoma and cirrhosis.
    Kew MC; Popper H
    Semin Liver Dis; 1984 May; 4(2):136-46. PubMed ID: 6087459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preneoplastic lesions in human hepatocarcinogenesis.
    Libbrecht L; Desmet V; Roskams T
    Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
    Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
    Kaczynski J
    Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma].
    Maillard E
    Cancer Radiother; 2011 Feb; 15(1):3-6. PubMed ID: 21239205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
    Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
    Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H; Kumada T; Kaneoka Y; Murakami Y
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.
    Caselmann WH; Alt M
    J Hepatol; 1996; 24(2 Suppl):61-6. PubMed ID: 8836891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clinicopathological study of primary liver cancer associated with alcoholic liver injury].
    Kohgo Y; Ohhira M; Ono M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1996 Apr; 31(2):155-63. PubMed ID: 8694740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macroregenerative nodules of the liver in primary biliary cirrhosis: report of two autopsy cases.
    Terada T; Kurumaya H; Nakanuma Y; Hayakawa Y; Matsuda H
    Am J Gastroenterol; 1989 Apr; 84(4):418-21. PubMed ID: 2539012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection.
    Trerè D; Borzio M; Morabito A; Borzio F; Roncalli M; Derenzini M
    Hepatology; 2003 Jan; 37(1):72-8. PubMed ID: 12500191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma.
    Hino O; Kajino K; Umeda T; Arakawa Y
    J Gastroenterol; 2002; 37(11):883-7. PubMed ID: 12483242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.